Adriamycin

Generic name: Doxorubicin
Drug class: Antibiotics / antineoplastics

Usage of Adriamycin

Adriamycin is used to treat different types of cancers that affect the breast, bladder, kidneys, ovaries, thyroid, stomach, lungs, bones, nerve tissues, joints, and soft tissues. This medicine is also used to treat Hodgkin lymphoma, non-Hodgkin lymphoma, and certain types of leukemia.

Adriamycin may also be used for purposes not listed in this medication guide.

Adriamycin side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some side effects may occur during the injection. Tell your caregiver right away if you feel dizzy, nauseated, light-headed, sweaty, or have a headache, chest tightness, back pain, trouble breathing, or swelling in your face.

Adriamycin may cause serious side effects. Call your doctor at once if you have:

pain, blisters, or skin sores where the injection was given;

missed menstrual periods;

easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin;

low white blood cell counts--fever, swollen gums, painful mouth sores, pain when swallowing, skin sores, cold or flu symptoms, cough, trouble breathing; or

signs of heart problems--fast heartbeats, shortness of breath (even with mild exertion), feeling very weak or tired, swelling in your ankles or feet.

Adriamycin may cause your urine to turn a reddish-orange color. This side effect is usually not harmful.

Common side effects of Adriamycin may include:

nausea, vomiting; or

hair loss.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Adriamycin

You should not use this medicine if you are allergic to Adriamycin or similar medications (this medicine, daunorubicin, epirubicin, idarubicin, mitoxantrone), or if you have:

very low blood cell counts caused by chemotherapy you received in the past;

severe liver disease;

severe heart problems; or

if you have recently had a heart attack.

Tell your doctor if you have ever had:

severe liver disease;

heart disease or heart failure; or

radiation treatment to your chest.

Tell your doctor about all other cancer medicines or radiation treatments you have received in the past.

Using Adriamycin may increase your risk of developing a bone marrow disease or other types of leukemia later in life. Ask your doctor about your specific risk.

You may need to have a negative pregnancy test before starting this treatment.

Both men and women using this medicine should use effective birth control to prevent pregnancy. Adriamycin can harm an unborn baby or cause birth defects if the mother or father is using this medicine.

Keep using birth control for at least 6 months after your last dose. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using Adriamycin.

This medicine may affect fertility (ability to have children) in both men and women. However, it is important to use birth control to prevent pregnancy because Adriamycin can harm an unborn baby.

Adriamycin may also cause early menopause, depending on your age when you receive this medicine. Ask your doctor about this risk.

You should not breastfeed while you are using Adriamycin.

Relate drugs

How to use Adriamycin

Adriamycin is given as an infusion into a vein. A healthcare provider will give you this injection.

Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when Adriamycin is injected.

Adriamycin is sometimes given together with other cancer medications. You may be given other medications to prevent nausea, vomiting, or infections.

If any of this medication accidentally gets on your skin, wash it thoroughly with soap and warm water.

Adriamycin can lower your blood cell counts. Your blood will need to be tested often. Your cancer treatments may be delayed based on the results.

Warnings

You should not use Adriamycin if you have severe liver disease, severe heart problems, very low blood cell counts caused by prior chemotherapy, or if you recently had a heart attack.

Adriamycin can weaken your immune system. Your blood may need to be tested often. Tell your doctor if you have unusual bruising or bleeding, or signs of infection (fever, chills, body aches).

Adriamycin may cause dangerous effects on your heart. Call your doctor at once if you feel very weak or tired, or have fast heartbeats, shortness of breath (even with mild exertion), or swelling in your ankles or feet.

What other drugs will affect Adriamycin

Many drugs can affect Adriamycin. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any medicine you start or stop using.

Popular FAQ

The chemotherapy (“chemo”) drug “The Red Devil” is doxorubicin (Adriamycin), an intravenous injection with a clear, bright red color used to treat various cancers. It may cause your urine or other body fluids to turn a reddish-orange color for 1 to 2 days after a dose is given, which is normal and temporary. Doxorubicin can also cause harsh side effects such as heart toxicity (heart failure), secondary cancers, severe vomiting and total hair loss (alopecia). Continue reading

Doxorubicin is considered one of the strongest chemotherapy drugs for breast cancer ever invented. It can kill cancer cells at every point in their life cycle, and it's used to treat a wide variety of cancers, not just breast cancer. Doxorubicin is also known as “The Red Devil” because it is a clear bright red color. It can cause your urine or other body fluids to turn a reddish color for 1 to 2 days after a dose is given, which is normal and temporary. Continue reading

Lartruvo (olaratumab) is given as an intravenous infusion on Days 1 and 8 of each 21-day cycle until disease progression or unacceptable toxicity. Lartruvo injection is used in combination with doxorubicin for the treatment of adult patients with soft tissue sarcoma (STS) who cannot be cured with radiation or surgery. Continue reading

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.